2021 annual financial data

ProQR Therapeutics N.V. 2021 Net margin

ProQR Therapeutics N.V. 2021 net margin with verified reported values.

Direct answer

Net margin was -4,549.81%.

Operating income was -57,210,000 EUR and net income was -60,740,000 EUR.
Operating cash flow was -26,012,000 EUR.

Get free ProQR Therapeutics N.V. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1,335,000 EUR
Operating income
-57,210,000 EUR
Net income
-60,740,000 EUR
Operating cash flow
-26,012,000 EUR